Ahn-Gook Pharmaceutical Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	7,481	16,845	1,290	6,875	3,939
Depreciation & Amortization	8,778	7,698	5,023	4,930	4,507
Loss (Gain) From Sale of Assets	-46.41	-13,216	-17.13	-28.25	-138.65
Asset Writedown & Restructuring Costs	2.75	219.98	-	37.78	-
Loss (Gain) From Sale of Investments	-989.18	-229.34	-920.69	889.36	-2,033
Loss (Gain) on Equity Investments	579.82	-1,352	1,641	1,645	-2,613
Provision & Write-off of Bad Debts	76.64	-83.27	757.97	129.7	171.68
Other Operating Activities	-269.03	8,165	4,747	5,478	8,724
Change in Accounts Receivable	30,226	3,541	-7,972	-11,980	-10,171
Change in Inventory	-8,710	-10,008	-12,861	-4,497	-3,969
Change in Accounts Payable	3,505	-4,931	2,569	2,528	1,090
Change in Other Net Operating Assets	5,049	-1,735	4,415	-4,219	1,964
Operating Cash Flow	45,683	4,914	-1,328	1,788	1,472
Operating Cash Flow Growth	829.63%	-	-	21.49%	-86.84%
Capital Expenditures	-8,465	-75,887	-5,474	-2,931	-4,035
Sale of Property, Plant & Equipment	6	11,833	11,201	15.5	42.09
Cash Acquisitions	-2,224	-	-	-	-
Sale (Purchase) of Intangibles	-131.34	-395.05	-708.77	-735.39	-1,028
Investment in Securities	-1,584	-10,938	12,167	9,960	4,931
Other Investing Activities	-	0	0	-0	62.75
Investing Cash Flow	-12,398	-75,386	17,186	6,431	3,118
Long-Term Debt Issued	-	60,000	10,000	-	-
Long-Term Debt Repaid	-5,244	-301.93	-12,593	-662.99	-889.69
Net Debt Issued (Repaid)	-5,244	59,698	-2,593	-662.99	-889.69
Repurchase of Common Stock	-	-	-	-554	-435.14
Dividends Paid	-5,001	-2,500	-2,500	-2,511	-2,521
Other Financing Activities	-	-0	-	-	-
Financing Cash Flow	-10,244	57,198	-5,093	-3,728	-3,846
Foreign Exchange Rate Adjustments	63.62	127.64	8.08	77.69	136.61
Net Cash Flow	23,104	-13,147	10,772	4,569	881.42
Free Cash Flow	37,218	-70,972	-6,802	-1,143	-2,563
Free Cash Flow Margin	12.13%	-26.18%	-2.91%	-0.56%	-1.57%
Free Cash Flow Per Share	3273.71	-6243.89	-598.47	-100.42	-223.77
Cash Interest Paid	2,807	2,665	976.99	662.47	121.11
Cash Income Tax Paid	5,461	652.73	2,921	713.85	101.29
Levered Free Cash Flow	37,633	-82,472	4,491	1,732	-988.07
Unlevered Free Cash Flow	39,355	-80,595	4,581	1,832	-915.05
Change in Working Capital	30,070	-13,134	-13,849	-18,168	-11,086

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.